GENERIC NAME OF THE MEDICINAL PRODUCT:

Gliclazide Modified Release Tablets IP 30mg
Gliclazide Modified Release Tablets IP 60mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

a) Gliclazide Modified Release Tablets IP 30mg
Each uncoated tablet contains:
Gliclazide IP……………………30mg
Excipients………………………...q.s.


b) Gliclazide Modified Release Tablets IP 60mg
Each uncoated tablet contains:
Gliclazide IP……………………60mg
Excipients………………………...q.s.

THERAPEUTIC INDICATIONS:

Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.

CAUTION & WARNING:

CAUTION:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.

STORAGE & DOSAGE:

Storage: Protect form moisture at a temperature not exceeding 25˚C. Do not freeze. Keep the container tightly closed in order to protect from moisture.
Dosage: As directed by the Physician.

Gliclazide Modified Release Tablets 30mg Technical Specification:

Product Name:
Gliclazide Modified Release Tablets IP 
Brand Name: DIAGLIZID
Strength: 30mg, 60mg
Dosage Form: Tablets (Uncoated)
Route of Administration: Via oral Route
Packing: 30s, 90s, 100s
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Regulatory Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Antidiabetic, hypoglycemic
Indication: Gliclazide is used to treat type 2 diabetes. It’s a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.
Storage: Protect form moisture at a temperature not exceeding 25˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Gliclazide Modified Release Tablets IP 30mg
  • Gliclazide Modified Release Tablets IP 60mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  •  a) Gliclazide Modified Release Tablets IP 30mg
    Each uncoated tablet contains:
    Gliclazide IP……………………30mg
    Excipients…………………………q.s.
  •  b) Gliclazide Modified Release Tablets IP 60mg
    Each uncoated tablet contains:
    Gliclazide IP……………………60mg
    Excipients…………………………q.s.

THERAPEUTIC INDICATIONS:

  • Gliclazide is used to treat type 2 diabetes. It’s a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.

CAUTION & WARNING:

  • CAUTION:
    Read enclosed leaflet before use.
    Keep medicine out of reach of children.
    SWALLOW WHOLE DO NOT CHEW OR CRUSH
  • SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.

STORAGE & DOSAGE:

  • Storage: Protect form moisture at a temperature not exceeding 25˚C. Do not freeze. Keep the container tightly closed in order to protect from moisture.
  • Dosage:  As directed by the Physician.

Introduction to gliclazide modified release tablets 30mg

Gliclazide modified release tablets 30mg are an essential oral anti-diabetic medication widely used for the management of type 2 diabetes mellitus in adults. Belonging to the sulfonylurea class, gliclazide works by stimulating insulin secretion from the pancreas, helping control blood glucose levels and reducing the risk of long-term complications such as kidney failure, nerve damage, and vision problems.

The modified release formulation ensures steady absorption over time, enabling once-daily dosing, improved compliance, and better glycemic control.

Due to the global surge in type 2 diabetes cases, the demand for gliclazide modified release tablets 30mg has significantly increased in both developed and emerging markets. Countries in Asia, Africa, the Middle East, and Latin America are witnessing rising prescription rates, making India—especially manufacturers like Taj Pharma—a critical supplier in the global pharmaceutical supply chain.


Detailed Information for Importers, Exporters & Buyers

Taj Pharma, as a leading gliclazide modified release tablets 30mg manufacturer and supplier in India, provides end-to-end export support for international buyers.

Regulatory Documentation Provided

When partnering with Taj Pharma, global buyers receive complete, compliant documentation to meet their market’s regulatory needs:

  • WHO-GMP Certificate

  • EU-GMP Approval (where applicable)

  • Certificate of Pharmaceutical Product (COPP)

  • Free Sale Certificate

  • Certificate of Analysis (COA)

  • Stability Data

  • CTD / ACTD Dossier for product registration

  • Batch Manufacturing Records

Custom Packaging & Labeling

Taj Pharma offers customizable packaging solutions:

  • Blister packs, alu-alu strips, bottle packs

  • Multilingual labeling as per importer’s regulatory guidelines

  • Branded or neutral export packing

  • Tamper-evident and moisture-protective materials

Shelf Life, Storage & Dosage Form

  • Shelf life: 24 to 36 months (depending on buyer requirements)

  • Storage: Store below 25°C, protect from moisture and light

  • Dosage form: Film-coated, modified release tablets, 30mg strength

Export Certifications

  • WHO-GMP (World Health Organization – Good Manufacturing Practice)

  • EU-GMP (European Union GMP)

  • ISO 9001:2015 Quality Management System

  • COPP (Certificate of Pharmaceutical Product)

  • Halal Certification (upon request)

Target Countries & Export Markets

Taj Pharma actively exports to over 40 countries, including:

  • Nigeria, Kenya, Ghana, Uganda

  • Vietnam, Philippines, Cambodia

  • UAE, Oman, Saudi Arabia, Qatar

  • Russia, Ukraine, Kazakhstan

  • Brazil, Chile, Peru

  • South Africa, Tanzania, Ethiopia


Why Taj Pharma is the Most Trusted Manufacturer/Supplier/Exporter

1. State-of-the-Art Manufacturing

Taj Pharma’s WHO-GMP compliant facility in Vapi, Gujarat, is equipped with:

  • Fully automated production lines

  • In-house R&D and quality control laboratories

  • Zero-contamination production zones

2. Affordable Pricing with Quality Assurance

Taj Pharma maintains cost efficiency without compromising quality, making their gliclazide modified release tablets 30mg competitively priced for global markets. Each batch undergoes stringent quality checks.

3. Global Presence & Supply Chain Support

With a strong distribution network across Asia, Africa, Latin America, and the Middle East, Taj Pharma ensures:

  • On-time deliveries

  • Assistance with import registrations

  • Long-term supply agreements

4. Top 20 Countries Exporting

Nigeria, Kenya, Ghana, Iraq, UAE, Saudi Arabia, Bangladesh, Sri Lanka, Vietnam, Ukraine, Uzbekistan, Colombia, Peru, Ecuador, Philippines, Tanzania, Myanmar, Cambodia, Jordan, Zambia


Technical Product Specification Table

Parameter Specification
Product Name Gliclazide Modified Release Tablets
Strength 30mg
Dosage Form Film-coated, modified release tablet
Therapeutic Category Anti-diabetic (Sulfonylurea)
Indication Type 2 Diabetes Mellitus
Packaging Options Blister packs, alu-alu strips, bottle packs
Shelf Life 24–36 months
Storage Conditions Below 25°C, protect from light and moisture
Manufacturing Standard WHO-GMP, EU-GMP
Regulatory Support COPP, CTD Dossier, COA, Stability Data
Origin India (Vapi, Gujarat)

If you are a pharmaceutical importer, distributor, or PCD franchise partner seeking a reliable supplier of gliclazide modified release tablets 30mg, Taj Pharma is your trusted partner.
Contact Today:
📧 export@tajpharma.com
🌐 www.tajpharma.com


Top 20 FAQs 

1. What is gliclazide modified release tablets 30mg used for?
It’s used to control blood sugar in adults with type 2 diabetes.

2. How does gliclazide work?
It stimulates insulin secretion, helping lower blood glucose.

3. What does “modified release” mean?
It releases the drug slowly over time, ensuring stable blood sugar control.

4. How should I take it?
Take once daily with breakfast; swallow whole with water.

5. Can I split or crush the tablet?
No. Crushing affects the slow-release mechanism.

6. What are the common side effects?
Nausea, stomach ache, constipation, diarrhea, or mild hypoglycemia.

7. Is it safe during pregnancy?
Consult your doctor before use during pregnancy.

8. Can it be taken with metformin?
Yes, often prescribed together for better control.

9. What happens if I miss a dose?
Take it when you remember unless it’s close to your next dose.

10. Can it cause low blood sugar?
Yes, especially if meals are skipped.

11. Who should avoid gliclazide?
Those with type 1 diabetes or severe kidney/liver problems.

12. Does Taj Pharma provide export documentation?
Yes, including COPP, COA, CTD dossier.

13. Can Taj Pharma customize packaging?
Yes, as per importer’s requirements.

14. Is Taj Pharma WHO-GMP certified?
Yes, WHO-GMP and EU-GMP compliant.

15. What is the shelf life?
24–36 months under proper storage.

16. Does it interact with other medicines?
Yes, consult your doctor before combining with other drugs.

17. Is it available for PCD pharma franchise?
Yes, Taj Pharma offers franchise opportunities.

18. Where is it manufactured?
At Taj Pharma’s WHO-GMP plant in Vapi, Gujarat.

19. Does Taj Pharma export to Africa?
Yes, to multiple African countries.

20. How can I order?
Contact Taj Pharma via email or phone for export inquiries.